Wikipedia -WSS

Wikipedia

author：focus 2025-09-27 22:49:38 - browse：29429

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma. — This immunofluorescence image shows T cells (in green and yellow) in the microenvironment of a head and neck squamous cell carcinoma. Allen Lab/NCI/NIH

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim analysis of an ongoing mid-stage clinical trial.

The new efficacy results, derived from a larger number of patients, look similar to an initial disclosure made last week that triggered a 36% increase in Merus’ stock price.

But the Dutch drugmaker on Tuesday withheld additional information from the study related to the safety and durability of petosemtamab’s tumor responses, pending presentation at the annual meeting of the American Society of Clinical Oncology on June 3.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： The Readout: Amylyx, Alumis, and Lundbeck drug updates

WSS

CDC marks new Covid

Sanofi CEO defends move to abandon profit guidance, boost research

IVF, abortion rights issues kick off Biden’s State of the Union

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Former medical device CEO who sold dummy, plastic parts convicted of fraud

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

entertainment

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Tori Bowie and the unacceptable rates of Black maternal death

Victims of gun violence feel impacts long after bullet wound

Medicare proposal to cover medical devices draws a mixed reaction

HPV cancer vaccine study demonstrates efficacy

Wildfire smoke exposes gaps in outdoor worker protections

Extreme heat events are a public health emergency

Continuity nursing helped my family in our darkest PICU moments

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

As demand for Covid shots wanes, Moderna seeks its next success

More doctors should go into startup world

explore

Just how do doctors, lawmakers, and the public define abortion?

Free speech concerns arise in wake of journal editor Eisen's firing

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The problem with charging patients to message their doctors

Former medical device CEO who sold dummy, plastic parts convicted of fraud

leisure time

explore

hotspot

Wikipedia